Emily Tribulski

Master(ing) Protocols For Randomized Umbrella And Platform Trials

The Long (Un)Winding Road, Part 2: The FDA's Final Transition Guidances For COVID-19 Devices

The Long (Un)Winding Road Part 2: FDA's Final Transition Guidances For COVID-19 Devices

The Long (Un)Winding Road: FDA Maps Out How The End Of The Public Health Emergency Will Impact Its COVID-19 Policies

Potential AI/ML Learnings To Come From FDA Public Advisory Committee Meeting On Skin Lesion Analyzer Technology In Late July